Fig. 5From: Cell membrane-based nanomaterials for theranostics of central nervous system diseasesPreparation procedures of cancer cell membrane-based nanomaterials of DWSW-CCM-(PTX)NS (A), B16-PCL-ICG or 4T1-PCL-ICG (B), ND-MMSNs (C) and MSCs-NPs (D). Reproduced with permission from Fan et al. [90], Wang et al. [92], Wu et al. [44], Wang et al. [60]Back to article page